Atai Life Sciences N.V. (ATAI)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 308.04M |
| Enterprise value | 147.92M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 930.75 |
| Price/book (mrq) | 1.27 |
| Enterprise value/revenue | 471.10 |
| Enterprise value/EBITDA | -4.07 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.98 |
| 52-week change 3 | -3.66% |
| S&P500 52-week change 3 | 21.08% |
| 52-week high 3 | 2.8500 |
| 52-week low 3 | 1.0250 |
| 50-day moving average 3 | 1.9752 |
| 200-day moving average 3 | 1.6358 |
Share statistics
| Avg vol (3-month) 3 | 1.63M |
| Avg vol (10-day) 3 | 1.19M |
| Shares outstanding 5 | 167.41M |
| Implied shares outstanding 6 | 167.41M |
| Float 8 | 127.01M |
| % held by insiders 1 | 9.99% |
| % held by institutions 1 | 28.02% |
| Shares short (15 Apr 2024) 4 | 5.9M |
| Short ratio (15 Apr 2024) 4 | 2.64 |
| Short % of float (15 Apr 2024) 4 | 4.62% |
| Short % of shares outstanding (15 Apr 2024) 4 | 3.53% |
| Shares short (prior month 15 Mar 2024) 4 | 5.21M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -186,483.33% |
Management effectiveness
| Return on assets (ttm) | -25.52% |
| Return on equity (ttm) | -17.21% |
Income statement
| Revenue (ttm) | 314k |
| Revenue per share (ttm) | 0.00 |
| Quarterly revenue growth (yoy) | -52.60% |
| Gross profit (ttm) | N/A |
| EBITDA | -121.95M |
| Net income avi to common (ttm) | -40.22M |
| Diluted EPS (ttm) | -0.2500 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 179.26M |
| Total cash per share (mrq) | 1.08 |
| Total debt (mrq) | 21.54M |
| Total debt/equity (mrq) | 8.82% |
| Current ratio (mrq) | 9.22 |
| Book value per share (mrq) | 1.46 |
Cash flow statement
| Operating cash flow (ttm) | -84.12M |
| Levered free cash flow (ttm) | -37.17M |
© 2024 Yahoo. All rights reserved.